Drug safety is an important enough topic that I am going to provide another post from the PharmaTech Talk blog that addresses the new Senate legislation proposed to enhance drug safety.
The blog post provides links to the bill, Drug Safety and Accountability Act of 2010, as well as to statements from interested parties like the Society for Chemical Manufacturers and Affiliates (SOCMA), the Bulk Pharmaceuticals Task Force (BPTF), and the Pharmaceutical Research and Manufacturers of America (PhRMA). SOCMA and the BPTF supported the proposed legislation effusively. PhRMA was a bit more reserved in its response, noting that GMP requirements are followed now whereever a drug is manufactured for the US market (or at least are supposed to be).
Posted by Bruce Lehr August 4th 2010.